Dempsey E M, Barrington K J
Department of Pediatrics, McGill University, Montréal, QC, Canada.
J Perinatol. 2007 Aug;27(8):469-78. doi: 10.1038/sj.jp.7211774.
A very large proportion of extremely preterm infants receive treatments for hypotension. There are, however, marked variations in indications for treatment, and in the interventions used, between neonatal intensive care units and between neonatologists.
We performed systematic reviews of the literature in order to determine which preterm infants may benefit from treatment with interventions to elevate blood pressure (BP), and which interventions improve clinically important outcomes.
Our review was not able to define a threshold BP that was significantly predictive of a poor outcome, nor whether any interventions for hypotensive infants improved outcomes, nor which interventions were more likely to be beneficial.
There is a distinct lack of prospective research of this issue, which prevents good clinical care. It is possible that a simple BP threshold that indicates the need for therapy does not exist, and other factors, such as the clinical status or systemic blood flow measurements, may be much more informative. Such a paradigm shift will also require careful prospective study.
很大比例的极早产儿接受了低血压治疗。然而,新生儿重症监护病房之间以及新生儿科医生之间在治疗指征和所采用的干预措施方面存在显著差异。
我们对文献进行了系统综述,以确定哪些早产儿可能从升高血压(BP)的干预治疗中获益,以及哪些干预措施能改善具有临床重要意义的结局。
我们的综述未能确定一个能显著预测不良结局的血压阈值,也无法确定对低血压婴儿的任何干预措施是否能改善结局,以及哪些干预措施更可能有益。
明显缺乏对此问题的前瞻性研究,这妨碍了良好的临床护理。可能不存在一个表明需要治疗的简单血压阈值,而其他因素,如临床状况或全身血流测量,可能更具参考价值。这种范式转变也需要仔细的前瞻性研究。